Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.06 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |